首页>
外国专利>
Potassium channel activators in the prevention and treatment of dystonia and dystonia-like symptoms
Potassium channel activators in the prevention and treatment of dystonia and dystonia-like symptoms
展开▼
机译:钾通道激活剂预防和治疗肌张力障碍和肌张力障碍样症状
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is directed to the prevention, reversal and medical treatment of dystonia and dyskinesia as well as other diseases related to movement disorders, both in human beings and animals by administering a neuronal potassium channel opener such as flupirtine, retigabine or maxipost.
展开▼